These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 14757158)

  • 1. Discovery of a novel protein tyrosine phosphatase-1B inhibitor, KR61639: potential development as an antihyperglycemic agent.
    Cheon HG; Kim SM; Yang SD; Ha JD; Choi JK
    Eur J Pharmacol; 2004 Feb; 485(1-3):333-9. PubMed ID: 14757158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New azolidinediones as inhibitors of protein tyrosine phosphatase 1B with antihyperglycemic properties.
    Malamas MS; Sredy J; Gunawan I; Mihan B; Sawicki DR; Seestaller L; Sullivan D; Flam BR
    J Med Chem; 2000 Mar; 43(5):995-1010. PubMed ID: 10715163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein tyrosine phosphatase 1B inhibitors as antidiabetic agents - A brief review.
    Verma M; Gupta SJ; Chaudhary A; Garg VK
    Bioorg Chem; 2017 Feb; 70():267-283. PubMed ID: 28043717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel benzofuran and benzothiophene biphenyls as inhibitors of protein tyrosine phosphatase 1B with antihyperglycemic properties.
    Malamas MS; Sredy J; Moxham C; Katz A; Xu W; McDevitt R; Adebayo FO; Sawicki DR; Seestaller L; Sullivan D; Taylor JR
    J Med Chem; 2000 Apr; 43(7):1293-310. PubMed ID: 10753467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small molecule peptidomimetics containing a novel phosphotyrosine bioisostere inhibit protein tyrosine phosphatase 1B and augment insulin action.
    Bleasdale JE; Ogg D; Palazuk BJ; Jacob CS; Swanson ML; Wang XY; Thompson DP; Conradi RA; Mathews WR; Laborde AL; Stuchly CW; Heijbel A; Bergdahl K; Bannow CA; Smith CW; Svensson C; Liljebris C; Schostarez HJ; May PD; Stevens FC; Larsen SD
    Biochemistry; 2001 May; 40(19):5642-54. PubMed ID: 11341829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular modeling of protein tyrosine phosphatase 1B (PTP 1B) inhibitors.
    Murthy VS; Kulkarni VM
    Bioorg Med Chem; 2002 Apr; 10(4):897-906. PubMed ID: 11836096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha-lipoic acid decreases thiol reactivity of the insulin receptor and protein tyrosine phosphatase 1B in 3T3-L1 adipocytes.
    Cho KJ; Moini H; Shon HK; Chung AS; Packer L
    Biochem Pharmacol; 2003 Sep; 66(5):849-58. PubMed ID: 12948866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, activity and molecular modeling of a new series of chromones as low molecular weight protein tyrosine phosphatase inhibitors.
    Forghieri M; Laggner C; Paoli P; Langer T; Manao G; Camici G; Bondioli L; Prati F; Costantino L
    Bioorg Med Chem; 2009 Apr; 17(7):2658-72. PubMed ID: 19297174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperglycemia potentiates H(2)O(2) production in adipocytes and enhances insulin signal transduction: potential role for oxidative inhibition of thiol-sensitive protein-tyrosine phosphatases.
    Wu X; Zhu L; Zilbering A; Mahadev K; Motoshima H; Yao J; Goldstein BJ
    Antioxid Redox Signal; 2005; 7(5-6):526-37. PubMed ID: 15889998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular design and biological activities of protein-tyrosine phosphatase inhibitors.
    Umezawa K; Kawakami M; Watanabe T
    Pharmacol Ther; 2003 Jul; 99(1):15-24. PubMed ID: 12804696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In silico structure-based design of a potent and selective small peptide inhibitor of protein tyrosine phosphatase 1B, a novel therapeutic target for obesity and type 2 diabetes mellitus: a computer modeling approach.
    Rao GS; Ramachandran MV; Bajaj JS
    J Biomol Struct Dyn; 2006 Feb; 23(4):377-84. PubMed ID: 16363874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphonate inhibitors of protein-tyrosine and serine/threonine phosphatases.
    Kole HK; Smyth MS; Russ PL; Burke TR
    Biochem J; 1995 Nov; 311 ( Pt 3)(Pt 3):1025-31. PubMed ID: 7487920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3D-QSAR CoMFA and CoMSIA on protein tyrosine phosphatase 1B inhibitors.
    Murthy VS; Kulkarni VM
    Bioorg Med Chem; 2002 Jul; 10(7):2267-82. PubMed ID: 11983524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein tyrosine phosphatase 1B in hematopoiesis.
    Heinonen KM; Tremblay ML
    Cell Cycle; 2006 May; 5(10):1053-6. PubMed ID: 16687929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein-tyrosine phosphatases are involved in interferon resistance associated with insulin resistance in HepG2 cells and obese mice.
    García-Ruiz I; Solís-Muñoz P; Gómez-Izquierdo E; Muñoz-Yagüe MT; Valverde AM; Solís-Herruzo JA
    J Biol Chem; 2012 Jun; 287(23):19564-73. PubMed ID: 22493491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-based optimization of benzoic acids as inhibitors of protein tyrosine phosphatase 1B and low molecular weight protein tyrosine phosphatase.
    Maccari R; Ottanà R; Ciurleo R; Paoli P; Manao G; Camici G; Laggner C; Langer T
    ChemMedChem; 2009 Jun; 4(6):957-62. PubMed ID: 19288492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein tyrosine phosphatase 1B inhibitors: a molecular level legitimate approach for the management of diabetes mellitus.
    Thareja S; Aggarwal S; Bhardwaj TR; Kumar M
    Med Res Rev; 2012 May; 32(3):459-517. PubMed ID: 20814956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel Imbricatolic acid derivatives as protein tyrosine phosphatase-1B inhibitors: Design, synthesis, biological evaluation and molecular docking.
    Khan MF; Azad CS; Kumar A; Saini M; Narula AK; Jain S
    Bioorg Med Chem Lett; 2016 Apr; 26(8):1988-92. PubMed ID: 26965864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances in protein tyrosine phosphatase 1B inhibitors.
    Taylor SD; Hill B
    Expert Opin Investig Drugs; 2004 Mar; 13(3):199-214. PubMed ID: 15013940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virtual screening, optimization, and identification of a novel specific PTP-MEG2 Inhibitor with potential therapy for T2DM.
    Wang M; Li X; Dong L; Chen X; Xu W; Wang R
    Oncotarget; 2016 Aug; 7(32):50828-50834. PubMed ID: 27384997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.